Top 5 News Articles in 2023
News about state bans on accumulators, Pfizer’s announcements about vaccines and cardiovascular deaths increasing because of climate change were the most viewed news items on the Managed Healthcare Executive website this year.
Here are the top five news articles published on the Managed Healthcare Executive website this year.\
States Are Moving to Ban Accumulators
Sixteen states have banned a pharmacy benefit management practice that involves not counting the value of drug copay assistance from manufacturers toward patient deductibles.
Vaccine Updates: Two Announcements From Pfizer
Pfizer and BioNTech released positive top-line data for their mRNA-based combination vaccine that targets influenza and COVID-19.
Study Predicts Alarming Increase in Cardiovascular Deaths Due to Impact of Extreme Heat
Recent data found that extreme heat is projected to lead to a significantly higher burden of excess cardiovascular deaths in the United States by midcentury (2036–2065), with elderly adults and non-Hispanic Black adults being most affected.
New Diabetes Therapeutic Will Sell for $750 for 90 Days, Company Says
However, patients who cannot get insurance coverage will be able to access AspyreRx at a significant self-pay discount.
UnitedHealthcare Removes Out-of-Pocket Costs for Eligible Members Using 24/7 Virtual Visits
Removing out-of-pocket expenses for virtual visits may help improve health equity by reducing medical costs for consumers and encourage earlier interventions.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 31st 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
First-in-Class Therapy for Diabetic Retinopathy Shows Six-Month Benefit | ASRS 2025
July 31st 2025PER-001, delivered through a slow-release, dissolvable implant in the vitreous cavity of the eye, is designed to block endothelin signaling to increase ocular blood flow and prevent vision loss.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
July 31st 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
